Drug Pipeline

Testosterone Cypionate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
10
Active Studies
6
Recruiting
8
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-16 NCT06305598
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for…		 date change Primary completion pushed: 2026-12-15 -> 2029-12-15
2026-05-16 NCT06305598
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for…		 date change Completion pushed: 2027-12-15 -> 2029-12-15
Active Studies by Phase
Phase 4
1
Phase 2
6
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07278362 Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under… Prostate Cancer Not Yet Recruiting
Phase 2
NCT06039371 Supraphysiological Androgen to Enhance Treatment Activity in Metastatic… Castration-Resistant Prostate Carcinoma Recruiting
NCT06059118 Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic… Prostate Cancer Recruiting
NCT07142551 Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Metastatic Castration-resistant Prostate Cancer Recruiting
NCT04363164 Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression Castration Resistant Metastatic Prostate Cancer Recruiting
NCT07476001 Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC Metastatic Castration-resistant Prostate Cancer Recruiting
NCT04558866 Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients… Prostate Cancer Active, Not Recruiting
Phase 1
NCT06305598 Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for… Castration-Resistant Prostate Carcinoma Recruiting
NCT04731376 Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative… Hypogonadism Active, Not Recruiting
Not specified
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
Sponsors Running Testosterone Cypionate Trials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) Latin American Cooperative Oncology Group (1) Emory University (1) University of Washington (1) Roswell Park Cancer Institute (1) University of Miami (1) H. Lee Moffitt Cancer Center and Research Institute (1) Enhanced Emirates Limited (1)
Disease Areas
Prostate Cancer (8)
Get alerts when Testosterone Cypionate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free